Announcements Trials
Browse Landscape

Phase

Phase 2 120Phase 3 24Phase 1/2 12Phase 1 9Phase NA 5Phase 4 3Phase 2/3 3

Status

Completed 6Unknown 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Stomach Neoplasms 2Small Cell Lung Carcinoma 1Neutropenia 1Colorectal Neoplasms 1

Interventions

Metformin 16Cyclophosphamide 16Drug Therapy 14Dexamethasone 14Cisplatin 13Cytarabine 11Gemcitabine 10Radiotherapy 9Oxaliplatin 9Carboplatin 9Vincristine 8Paclitaxel 8Idarubicin 8Etoposide 8Docetaxel 8ulipristal acetate 7icotinib 7Sodium Chloride 7Methotrexate 7Fluorouracil 7Dexmedetomidine 7entecavir 6Thalidomide 6Surgical Procedures, Operative 6Sorafenib 6Pemetrexed 6Leuprolide 6Granulocyte Colony-Stimulating Factor 6Epirubicin 6Doxorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Irinotecan × Clear all
NCT01271582 2019-01-29

Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients

Asan Medical Center

Phase 4 Unknown
1,500 enrolled
Gastrointestinal

Neutropenia, Stomach Neoplasms, Colorectal Neoplasms

NCT02348450 2016-12-05

Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer

Guangdong Association of Clinical Trials

Phase 4 Unknown
308 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT02401971 2015-03-30

ITAGC

Zhengzhou University

Phase 4 Unknown
900 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡